{"brief_title": "Effects of Arzoxifene on Bone Fractures and Incidence of Breast Cancer", "brief_summary": "The purpose of this trial is to study: - Effects of arzoxifene on bone fractures and bone mass. - Effects of arzoxifene on getting breast cancer. - Effects of arzoxifene on certain types of cardiovascular events, such as heart attack and stroke. - Effects of arzoxifene that changes the amount of certain substances in the blood that are related to osteoporosis and cardiovascular health. - Effects of arzoxifene on the uterus. - The safety of arzoxifene and any side effects.", "condition": ["Osteoporosis, Postmenopausal"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Arzoxifene", "Placebo"], "description": ["20mg, oral, tablet, once a day for 36 months", "oral, tablet, once a day for 36 months"], "arm_group_label": ["1", "2"], "other_name": ["LY353381"], "criteria": "Inclusion Criteria: - 60-85 years of age - Female - At least two years since last menstrual cycle Exclusion Criteria: - Abnormal or unexplained vaginal bleeding. - Bone disorders, other than osteoporosis or low bone mass - History of breast cancer, cancer of the uterus, or any cancer in the last five years (except skin cancer). - History of cerebral vascular accidents or venous thromboembolic events - Medications outlined", "gender": "Female", "minimum_age": "60 Years", "maximum_age": "85 Years", "healthy_volunteers": "No", "mesh_term": ["Osteoporosis", "Osteoporosis, Postmenopausal"], "id": "NCT00088010"}